$416 Million is the total value of Marotta Asset Management's 100 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IBB | ISHARES NASDAQ BIOTECHNOLOGY | $543,707,000 | +9.0% | 3,293 | 0.0% | 0.13% | +1.6% | |
D | DOMINION RES INC VA NEW | $383,513,000 | -2.1% | 5,175 | 0.0% | 0.09% | -8.0% | |
FISV | FISERV INC | $346,688,000 | -11.3% | 3,200 | 0.0% | 0.08% | -17.0% | |
CCOI | COGENT COMMUN GROUP NEW | $310,389,000 | +12.3% | 4,041 | 0.0% | 0.07% | +4.2% | |
NVR | N V R INC | $301,602,000 | +6.8% | 59 | 0.0% | 0.07% | 0.0% | |
NSC | NORFOLK SOUTHERN CORP | $282,205,000 | -0.7% | 1,048 | 0.0% | 0.07% | -6.8% | |
NKE | NIKE INC B | $242,530,000 | +19.2% | 1,535 | 0.0% | 0.06% | +11.5% | |
GXF | GLOBAL X FTSE NORDIC 30 ETF | $221,307,000 | +7.7% | 7,184 | 0.0% | 0.05% | 0.0% | |
BAC | BANK OF AMERICA CORP | $215,925,000 | +5.2% | 5,198 | 0.0% | 0.05% | 0.0% | |
AMPE | AMPIO PHARMACEUTICAL | $40,560,000 | -8.6% | 24,000 | 0.0% | 0.01% | -9.1% | |
ACRX | ACELRX PHARMACEUTICALS | $15,240,000 | -20.0% | 11,206 | 0.0% | 0.00% | -20.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-07-09
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VANGUARD MID CAP VALUE ETF | 16 | Q4 2023 | 7.9% |
VANGUARD FTSE EMERGING MARKET ETF | 16 | Q4 2023 | 7.0% |
VANGUARD INFO TECHNOLOGY ETF | 16 | Q4 2023 | 7.5% |
VANGUARD EMERGING MARKET GOVT BOND ETF | 16 | Q4 2023 | 7.9% |
VANGUARD TOTAL INTERNATIONAL BOND ETF | 16 | Q4 2023 | 6.4% |
VANGUARD SMALL CAP VALUE ETF | 16 | Q4 2023 | 5.2% |
SCHWAB SHORT TERM US TREASURY | 16 | Q4 2023 | 5.0% |
SCHWAB US AGGREGATE BOND ETF | 16 | Q4 2023 | 8.6% |
VANGUARD HEALTH CARE ETF | 16 | Q4 2023 | 4.6% |
SCHWAB US TIPS ETF | 16 | Q4 2023 | 5.1% |
View Marotta Asset Management's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-02 |
13F-HR | 2024-01-03 |
13F-HR | 2023-10-11 |
13F-HR | 2023-07-05 |
13F-HR | 2023-01-03 |
13F-HR | 2022-10-11 |
13F-HR | 2022-07-21 |
13F-HR | 2022-04-08 |
13F-HR | 2022-01-13 |
13F-HR | 2021-10-21 |
View Marotta Asset Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.